Mike Pykosz, who joined CVS with its acquisition of the value-based medical chain in 2023, is departing amid a flurry of high ...
Pykosz, who co-founded Oak Street Health and was CEO when it was acquired by CVS in 2023, has decided to leave the company ...
CVS is continuing to see leadership changes under new CEO David Joyner. Dr. Sreekanth Chaguturu will take on the role of ...
Still, according to CVS, 80% of the prescriptions for the four top-selling drugs, from Novo Nordisk (NVO) and Eli Lilly (LLY), are for Type 2 diabetes patients. Chaguturu said the PBMs will ...
Dr. Mullan (pictured) is a professor of medicine and healthy policy at George Washington University, Washington, D.C. Dr. Chaguturu is a resident in internal medicine at Massachusetts General ...
Mike Pykosz, the former CEO of Oak Street Health, will leave CVS Health as part of the company's latest leadership shake-up.